| Q35874415 | A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade |
| Q35785031 | A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe |
| Q40156071 | A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat. |
| Q24794033 | Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides |
| Q92906228 | Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease |
| Q44111908 | Blocking HIV replication by targeting Tat protein |
| Q36438574 | CXC and CC chemokine receptors on coronary and brain endothelia |
| Q34129756 | Chemokines and their receptors in infectious disease |
| Q35198110 | Chemokines and viruses: friends or foes? |
| Q36961218 | Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection |
| Q37347813 | Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. |
| Q59511395 | Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine |
| Q33786297 | Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes |
| Q40676905 | Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein. |
| Q34425378 | Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes |
| Q37033190 | Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells |
| Q34033148 | From the outside in: extracellular activities of HIV Tat. |
| Q36520900 | HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells |
| Q35552889 | HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial |
| Q34556390 | HIV-1 Tat vaccines |
| Q90221085 | HIV-1 Tat: Role in Bystander Toxicity |
| Q33581852 | HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells |
| Q34477471 | HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies |
| Q33671675 | HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1 |
| Q36986644 | HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial |
| Q33825196 | Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. |
| Q24564662 | Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression |
| Q40565403 | Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells |
| Q34234127 | Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors |
| Q34792498 | Human retroviruses after 20 years: a perspective from the past and prospects for their future control |
| Q52541976 | Immunization with a novel HIV-1-Tat multiple-peptide conjugate induces effective immune response in mice. |
| Q33908773 | Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis |
| Q21245111 | Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells |
| Q51998598 | Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys. |
| Q28211059 | Macrophage inflammatory protein-1 |
| Q45742451 | Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33). |
| Q37509718 | Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications |
| Q35020357 | Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. |
| Q45722188 | Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA. |
| Q39683362 | Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein |
| Q40508633 | Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells |
| Q58853523 | Prediction of human-Bacillus anthracis protein–protein interactions using multi-layer neural network |
| Q24799564 | Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes |
| Q33769035 | Regulation of HIV-1 transcription |
| Q43000456 | Replication of HIV-1 viruses in the presence of the Portland alpha1-antitrypsin variant (alpha1-PDX) inhibitor |
| Q37519397 | Role of Tat protein in HIV neuropathogenesis |
| Q24673389 | Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1 |
| Q39023036 | Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein |
| Q40273841 | Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein |
| Q77914240 | Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling |
| Q37605089 | Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages |
| Q42273481 | T-Cell Signaling in HIV-1 Infection |
| Q35993736 | Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine |
| Q39130522 | Tat is a multifunctional viral protein that modulates cellular gene expression and functions |
| Q24524076 | Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway |
| Q34755910 | Tat-neutralizing antibodies in vaccinated macaques |
| Q34218503 | The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10. |
| Q34460375 | The basis for HIV immunotherapeutic vaccines |
| Q81571700 | The binding affinity of double-stranded RNA motifs to HIV-1 Tat protein affects transactivation and the neutralizing capacity of anti-Tat antibodies elicited after intranasal immunization |
| Q42175449 | The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients |
| Q33320187 | The landscape of human proteins interacting with viruses and other pathogens |
| Q26823236 | The macrophage: a therapeutic target in HIV-1 infection |
| Q38273151 | The two sides of Tat. |
| Q28476094 | Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART |
| Q22010658 | Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization |
| Q35024694 | Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein |
| Q48382561 | Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains |
| Q45012988 | Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). |
| Q35114827 | Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques |
| Q33933260 | Viral exploitation and subversion of the immune system through chemokine mimicry |
| Q26780313 | Virological Mechanisms in the Coinfection between HIV and HCV |